Results show that expression levels of 8 of the 9 genes, i.e., ACAT1, ACAT2, BDH1, BDH2, HADHB, HMGCL, HMGCS1, and OXCT1, were significantly downregulated in AML (Figure 1A). This evidence concerns the gene BDH2 and acute myeloid leukemia.